SLB CEO Le Peuch sells 25,000 shares under plan

SLB LIMITED/NV Chief Executive Officer Olivier Le Peuch sold 25,000 shares of common stock in an open-market transaction.

Rhea-AI Filing Summary

SLB LIMITED/NV Chief Executive Officer Olivier Le Peuch sold 25,000 shares of common stock in an open-market transaction. The sale took place on February 25, 2026 at a price of $52.00 per share, pursuant to a pre-established Rule 10b5-1 trading plan.

After this transaction, Le Peuch directly owned 1,434,044 shares of SLB common stock. A Rule 10b5-1 plan allows insiders to schedule trades in advance, helping separate personal trading activity from day-to-day corporate developments.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 1 txn

Insider Le Peuch Olivier

Role Chief Executive Officer

Sold 25,000 shs ($1.30M)

Type	Security	Shares	Price	Value
Sale	Common Stock, $0.01 Par Value Per Share	25,000	$52.00	$1.30M

Holdings After Transaction: Common Stock, $0.01 Par Value Per Share — 1,434,044 shares (Direct)

Footnotes (1)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

FAQ

What insider transaction did SLB (SLB) report for Olivier Le Peuch?

SLB reported that CEO Olivier Le Peuch sold 25,000 shares of common stock. The transaction occurred on February 25, 2026 as an open-market sale executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 25, 2025.

At what price did SLB CEO Olivier Le Peuch sell his shares?

Olivier Le Peuch sold 25,000 SLB common shares at $52.00 per share. The filing characterizes the transaction as an open-market or private sale, executed under a Rule 10b5-1 trading plan designed to structure insider trades in advance.

How many SLB shares does Olivier Le Peuch own after this Form 4 sale?

Following the reported sale, Olivier Le Peuch directly owns 1,434,044 SLB common shares. This figure reflects his holdings after disposing of 25,000 shares in the February 25, 2026 open-market transaction disclosed in the Form 4 filing.

Was the SLB CEO’s February 2026 share sale under a Rule 10b5-1 plan?

Yes. The footnote explains the sales were effected under a Rule 10b5-1 trading plan. That plan was adopted by the reporting person on March 25, 2025, allowing trades to occur automatically according to pre-set instructions rather than day-to-day discretion.

Does the SLB Form 4 indicate whether the CEO’s transaction was a buy or sell?

The Form 4 clearly identifies the transaction as a sale. It uses transaction code “S” and describes the action as an open-market sale of 25,000 shares at $52.00 per share, leaving Olivier Le Peuch with 1,434,044 directly owned shares afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 05:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Le Peuch Olivier

(Last) (First) (Middle)

5599 SAN FELIPE, 17TH FLOOR

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SLB LIMITED/NV [ SLB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 Par Value Per Share	02/25/2026		S		25,000(1)	D	$52	1,434,044	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2025

	/s/ LaToyia Tilley, Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.